Works matching DE "BISPECIFIC antibodies"

Results: 1312

Bispecific Antibodies, Nanobodies and Extracellular Vesicles: Present and Future to Cancer Target Therapy.

Published in:

Biomolecules (2218-273X), 2025, v. 15, n. 5, p. 639, doi. 10.3390/biom15050639

By:

Lizama-Muñoz, Asier;
Plaza-Diaz, Julio

Publication type:

Article

The first case of Teclistamab interference with serum electrophoresis and immunofixation.

Published in:

2025

By:

Kadkhoda, Kamran;
Faiman, Beth;
Valent, Jason;
Albahra, Samer;
Boyert, Nicole

Publication type:

Letter

Physiologically Based Pharmacokinetic Modeling of Biologic Case Studies in Monkeys and Humans Reveals the Necessity of an Additional Clearance Term.

Published in:

Pharmaceutics, 2025, v. 17, n. 5, p. 560, doi. 10.3390/pharmaceutics17050560

By:

Stader, Felix;
Sharma, Pradeep;
Huang, Weize;
Choules, Mary P.;
Willemin, Marie-Emilie;
Zhang, Xinwen;
Yau, Estelle;
Derbalah, Abdallah;
Zyla, Adriana;
Liu, Cong;
Sepp, Armin

Publication type:

Article

The changing landscape of secondary malignancies.

Published in:

Acta Haematologica Polonica, 2025, v. 56, n. 2, p. 73, doi. 10.5603/ahp.106060

By:

Puła, Bartosz

Publication type:

Article

CAR-T and monoclonal antibodies in treatment of refractory precursor B-cell acute lymphoblastic leukemia in children: a single-center retrospective analysis.

Published in:

Acta Haematologica Polonica, 2025, v. 56, n. 2, p. 117, doi. 10.5603/ahp.103180

By:

Stręk-Cholewińska, Angelika;
Stolpa, Weronika;
Sordyl, Joanna;
Mizia-Malarz, Agnieszka

Publication type:

Article

Epidemiology and approaches for management of relapsed and refractory multiple myeloma in Gulf Countries: a narrative review and insights from the Gulf multiple myeloma experts.

Published in:

Current Medical Research & Opinion, 2025, v. 41, n. 4, p. 593, doi. 10.1080/03007995.2025.2502125

By:

Alhuraiji, Ahmad;
Lal, Amar;
Al Mehairi, Amna;
Alam, Arif;
Mudawi, Deena;
Khan, Faraz;
Al Nabhani, Ibrahim;
El-Najjar, Inas;
AL-farsi, Khalil;
K Rana, Shabeeha;
Wagdy, Tharwat;
Yassin, Mohamed A.;
Rodríguez Otero, Paula;
Haddadin, Haya;
Aljabban, Ali

Publication type:

Article

Multiformat T-Cell-Engaging Bispecific Antibodies Targeting Human Breast Cancers.

Published in:

Angewandte Chemie, 2015, v. 127, n. 24, p. 7128, doi. 10.1002/ange.201500799

By:

Cao, Yu;
Axup, Jun Y.;
Ma, Jennifer S. Y.;
Wang, Rongsheng E.;
Choi, Seihyun;
Tardif, Virginie;
Lim, Reyna K. V.;
Pugh, Holly M.;
Lawson, Brian R.;
Welzel, Gus;
Kazane, Stephanie A.;
Sun, Ying;
Tian, Feng;
Srinagesh, Shailaja;
Javahishvili, Tsotne;
Schultz, Peter G.;
Kim, Chan Hyuk

Publication type:

Article

Targeting Human C-Type Lectin-like Molecule-1 (CLL1) with a Bispecific Antibody for Immunotherapy of Acute Myeloid Leukemia.

Published in:

Angewandte Chemie, 2014, v. 126, n. 37, p. 9999, doi. 10.1002/ange.201405353

By:

Lu, Hua;
Zhou, Quan;
Deshmukh, Vishal;
Phull, Hardeep;
Ma, Jennifer;
Tardif, Virginie;
Naik, Rahul R.;
Bouvard, Claire;
Zhang, Yong;
Choi, Seihyun;
Lawson, Brian R.;
Zhu, Shoutian;
Kim, Chan Hyuk;
Schultz, Peter G.

Publication type:

Article

Bispecific antibodies in clinical practice: Understanding recent advances and current place in cancer treatment landscape.

Published in:

Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01520-y

By:

Verma, Vaibhav;
Sharma, Geeti

Publication type:

Article

Identification of Escherichia coli host cell for high plasmid stability and improved production of antihuman ovarian carcinoma × antihuman CD3 single-chain bispecific antibody.

Published in:

Applied Microbiology & Biotechnology, 2007, v. 76, n. 4, p. 795, doi. 10.1007/s00253-007-1050-5

By:

Zhao, Jing-Bo;
Wei, Dong-Zhi;
Tong, Wang-Yu

Publication type:

Article

PRE-TARGETING BISPECIFIC ANTIBODY (BSAB) AND PEGYLATED LIPOSOMAL DRUG NANOCARRIER AS MANAGEMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN PEDIATRICS.

Published in:

Eduvest: Journal Of Universal Studies, 2025, v. 5, n. 3, p. 2756, doi. 10.59188/eduvest.v5i3.1768

By:

Mareska, Viona;
Halim, Wilson;
Arim Sadeva, Gede Krishna

Publication type:

Article

β-cell-specific deletion of PFKFB3 restores cell fitness competition and physiological replication under diabetogenic stress.

Published in:

Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03209-y

By:

Min, Jie;
Ma, Feiyang;
Seyran, Berfin;
Pellegrini, Matteo;
Greeff, Oppel;
Moncada, Salvador;
Tudzarova, Slavica

Publication type:

Article

Human immunocompetent choroid-on-chip: a novel tool for studying ocular effects of biological drugs.

Published in:

Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-021-02977-3

By:

Cipriano, Madalena;
Schlünder, Katharina;
Probst, Christopher;
Linke, Kirstin;
Weiss, Martin;
Fischer, Mona Julia;
Mesch, Lena;
Achberger, Kevin;
Liebau, Stefan;
Mesquida, Marina;
Nicolini, Valeria;
Schneider, Anneliese;
Giusti, Anna Maria;
Kustermann, Stefan;
Loskill, Peter

Publication type:

Article

Epsilon-caprolactone-modified polyethylenimine as a genetic vehicle for stem cell-based bispecific antibody and exosome synergistic therapy.

Published in:

Regenerative Biomaterials, 2023, v. 10, p. 1, doi. 10.1093/rb/rbac090

By:

Tan, Yan;
Cai, Jiali;
Wang, Zhiyong

Publication type:

Article

An Integrated In Vivo/In Vitro Protein Production Platform for Site-Specific Antibody Drug Conjugates.

Published in:

Bioengineering (Basel), 2023, v. 10, n. 3, p. 304, doi. 10.3390/bioengineering10030304

By:

Hanson, Jeffrey;
Groff, Dan;
Carlos, Abi;
Usman, Hans;
Fong, Kevin;
Yu, Abigail;
Armstrong, Stephanie;
Dwyer, Allison;
Masikat, Mary Rose;
Yuan, Dawei;
Tran, Cuong;
Heibeck, Tyler;
Zawada, James;
Chen, Rishard;
Hallam, Trevor;
Yin, Gang

Publication type:

Article

Targeting EGFR Exon 20 Insertion-mutated Cancers – New Perspectives in Head and Neck Cancers – Lessons to Learn from Non-small Cell Carcinoma (NSCLC).

Published in:

Medicina Moderna, 2022, v. 29, n. 3, p. 181, doi. 10.31689/rmm.2022.29.3.181

By:

MIRESTEAN, Camil Ciprian;
IANCU, Roxana Irina;
IANCU, Dragos Teodor

Publication type:

Article

Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8<sup>+</sup> T cells.

Published in:

Clinical & Translational Immunology, 2024, v. 13, n. 11, p. 1, doi. 10.1002/cti2.70014

By:

Christo, Susan N;
McDonald, Keely M;
Burn, Thomas N;
Kurd, Nadia;
Stanfield, Jessica;
Kaneda, Megan M;
Seelige, Ruth;
Dillon, Christopher P;
Fisher, Timothy S;
Baaten, Bas;
Mackay, Laura K

Publication type:

Article

Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity.

Published in:: 2022
Publication type:: Correction Notice

Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity.

Published in:

Clinical & Translational Immunology, 2019, v. 8, n. 10, p. N.PAG, doi. 10.1002/cti2.1081

By:

Dougall, William C.;
Roman Aguilera, Amelia;
Smyth, Mark J.

Publication type:

Article

Latest evidence on immunotherapy for cholangiocarcinoma.

Published in:

Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12244

By:

Guo, Xurui;
Shen, Weizhang

Publication type:

Article

Evaluation of pollinator effectiveness based on pollen deposition and seed production in a gynodieocious alpine plant, Cyananthus delavayi.

Published in:

Ecology & Evolution (20457758), 2017, v. 7, n. 20, p. 8156, doi. 10.1002/ece3.3391

By:

Wang, Hao;
Cao, Guo-Xing;
Wang, Lin-Lin;
Yang, Yong-Ping;
Zhang, Zhi-Qiang;
Duan, Yuan-Wen

Publication type:

Article

The magnitude of behavioral isolation is affected by characteristics of the mating community.

Published in:

Ecology & Evolution (20457758), 2014, v. 4, n. 14, p. 2945, doi. 10.1002/ece3.1142

By:

Matute, Daniel R.

Publication type:

Article

Applied Cardio-Oncology in Hematological Malignancies: A Narrative Review.

Published in:

Life (2075-1729), 2024, v. 14, n. 4, p. 524, doi. 10.3390/life14040524

By:

Mandala, Evdokia;
Lafara, Kyranna;
Kokkinovasilis, Dimitrios;
Kalafatis, Ioannis;
Koukoulitsa, Vasiliki;
Katodritou, Eirini;
Lafaras, Christos

Publication type:

Article

Real-World Data on Faricimab Switching in Treatment-Refractory Neovascular Age-Related Macular Degeneration.

Published in:

Life (2075-1729), 2024, v. 14, n. 2, p. 193, doi. 10.3390/life14020193

By:

Ng, Benjamin;
Kolli, Hema;
Ajith Kumar, Naduviledeth;
Azzopardi, Matthew;
Logeswaran, Abison;
Buensalido, Julius;
Mushtaq, Bushra;
Chavan, Randhir;
Chong, Yu Jeat

Publication type:

Article

Preparation of a Growth Hormone Receptor/Prolactin Receptor Bispecific Antibody Antagonist Which Exhibited Anti-Cancer Activity.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.598423

By:

Chen, Xin;
Wu, Di;
Zheng, Yan;
Liu, Xingxing;
Wang, Jianmeng

Publication type:

Article

In vivo Phage Display: A promising selection strategy for the improvement of antibody targeting and drug delivery properties.

Published in:

Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.962124

By:

André, Ana S.;
Moutinho, Isa;
Dias, Joana N. R.;
Aires-da-Silva, Frederico

Publication type:

Article

TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02044

By:

Tawfik, Doaa;
Groth, Christopher;
Gundlach, Jan-Paul;
Peipp, Matthias;
Kabelitz, Dieter;
Becker, Thomas;
Oberg, Hans-Heinrich;
Trauzold, Anna;
Wesch, Daniela

Publication type:

Article

Dual Function pH Responsive Bispecific Antibodies for Tumor Targeting and Antigen Depletion in Plasma.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01892

By:

Bogen, Jan P.;
Hinz, Steffen C.;
Grzeschik, Julius;
Ebenig, Aileen;
Krah, Simon;
Zielonka, Stefan;
Kolmar, Harald

Publication type:

Article

Killing of human leukaemia/lymphoma B cells by activated cytotoxic T lymphocytes in the presence of a bispecific monoclonal antibody (αCD3/αCD19).

Published in:

Clinical & Experimental Immunology, 1992, v. 90, n. 3, p. 368

By:

Haagen, L. A.;
Griend, R. van de;
Clark, M.;
Geerars, A.;
Bast, B.;
De Gast, B.

Publication type:

Article

Bispecific anti-human red blood Rhesus-D antigen × anti FcγRI targeted antibody-dependent cell-mediated cytotoxicity and phagocytosis by mononuclear leucocytes.

Published in:

Clinical & Experimental Immunology, 1992, v. 89, n. 2, p. 310

By:

Deramoudt, F.-X.;
Gilard, C.;
Lepine, N.;
Alonso, J.-M.;
Romet-Lemonne, J.-L.

Publication type:

Article

Intra-Ocular Inflammation and Occlusive Retinal Vasculitis Following Intravitreal Injections of Faricimab: A Case Report.

Published in:

2024

By:

Chen, Xiuju;
Wang, Xiaobo;
Li, Xiaoxin

Publication type:

Case Study

Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer.

Published in:

ImmunoTargets & Therapy, 2025, v. 14, p. 339, doi. 10.2147/ITT.S495751

By:

Corti, Chiara;
Koca, Beyza;
Rahman, Tasnim;
Mittendorf, Elizabeth A;
Tolaney, Sara M

Publication type:

Article

Targeting CD22 for the Treatment of B-Cell Malignancies.

Published in:

ImmunoTargets & Therapy, 2021, v. 10, p. 225, doi. 10.2147/ITT.S288546

By:

Shah, Nikesh N;
Sokol, Lubomir

Publication type:

Article

Immunotherapeutic and Targeted Approaches in Multiple Myeloma.

Published in:

ImmunoTargets & Therapy, 2020, v. 9, p. 201, doi. 10.2147/ITT.S240886

By:

Nadeem, Omar;
Tai, Yu-Tzu;
Anderson, Kenneth C

Publication type:

Article

Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation.

Published in:

Journal of Biomedical Research, 2024, v. 38, n. 6, p. 531, doi. 10.7555/JBR.38.20240009

By:

Chasov, Vitaly;
Zmievskaya, Ekaterina;
Ganeeva, Irina;
Gilyazova, Elvina;
Davletshin, Damir;
Filimonova, Maria;
Valiullina, Aygul;
Kudriaeva, Anna;
Bulatov, Emil

Publication type:

Article

Tuning the Assembly of Bispecific Antibodies by Playing on Differential Polypeptide Chain Molar Ratios.

Published in:

Biotechnology & Bioprocess Engineering, 2023, v. 28, n. 4, p. 658, doi. 10.1007/s12257-023-0057-9

By:

De Temmerman, Célia;
Bernard, Pauline;
Aeberli, Quentin;
Braito, Sarah;
Arib, Ghislaine;
Girod, Pierre-Alain;
Fagète, Séverine

Publication type:

Article

Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy.

Published in:

Biotechnology & Bioprocess Engineering, 2021, v. 26, n. 3, p. 295, doi. 10.1007/s12257-020-0181-8

By:

Kang, Seung Hyun;
Lee, Chang-Han

Publication type:

Article

Nephrotoxicity in Bispecific Antibodies Recipients: Focus on T-Cell-Engaging Bispecific Antibodies.

Published in:

OncoTargets & Therapy, 2024, v. 17, p. 545, doi. 10.2147/OTT.S465679

By:

Wen, Xiaoli;
Xu, Gaosi

Publication type:

Article

Taking the Next Step in Double Refractory Disease: Current and Future Treatment Strategies for Chronic Lymphocytic Leukemia.

Published in:

OncoTargets & Therapy, 2024, v. 17, p. 181, doi. 10.2147/OTT.S443924

By:

Hayama, Manabu;
Riches, John C

Publication type:

Article

Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context.

Published in:

OncoTargets & Therapy, 2023, v. 16, p. 617, doi. 10.2147/OTT.S372783

By:

Abdulhaq, Haifaa;
Hwang, Andrew;
Mahmood, Omar

Publication type:

Article

Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives.

Published in:

OncoTargets & Therapy, 2023, v. 16, p. 441, doi. 10.2147/OTT.S370880

By:

Shrivastava, Trilok;
Van Rhee, Frits;
Hadidi, Samer Al

Publication type:

Article

Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options.

Published in:

OncoTargets & Therapy, 2022, v. 15, p. 1481, doi. 10.2147/OTT.S326632

By:

Vodicka, Prokop;
Klener, Pavel;
Trneny, Marek

Publication type:

Article

Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations.

Published in:

OncoTargets & Therapy, 2022, v. 15, p. 1197, doi. 10.2147/OTT.S329095

By:

Petrini, Iacopo;
Giaccone, Giuseppe

Publication type:

Article

Complete Response to PD-1 Inhibitor in Primary Hepatocellular Carcinoma Patients Post-Progression on Bi-Specific Antibody Conjugated CIK Cell Treatment: A Report of Two Cases.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5447, doi. 10.2147/OTT.S333604

By:

Wu, Tong;
Zhang, Linzhi;
Zeng, Zhen;
Yan, Tao;
Cheng, Jiamin;
Miao, Xiaojie;
Lu, Yinying

Publication type:

Article

Combination Therapy with iRGD-antiCD3 and PD-1 Blockade Enhances Antitumor Potency of Cord Blood-Derived T Cells.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 835, doi. 10.2147/OTT.S291086

By:

Zhu, Mei;
Wang, Hongmei;
Zhou, Shujuan;
Wei, Jia;
Ding, Naiqing;
Shao, Jie;
Yu, Lixia;
Feng, Zhenqing;
Liu, Baorui

Publication type:

Article

Identification and Targeting of Thomsen–Friedenreich and IL1RAP Antigens on Chronic Myeloid Leukemia Stem Cells Using Bi-Specific Antibodies.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 609, doi. 10.2147/OTT.S255299

By:

Eldesouki, Raghda E;
Wu, Chengxiang;
Saleh, Fayez M;
Mohammed, Eman Abdel-Moemen;
Younes, Soha;
Hassan, Naglaa Elsayed;
Brown, Theresa C;
Alt, Eckhard U;
Robinson, James E;
Badr, Fouad Mohamed;
Braun, Stephen E

Publication type:

Article

CD20 xCD3 bispecific antibodies for large B cell lymphoma: latest updates from 2024 ASH annual meeting.

Published in:

Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01695-1

By:

Tomarchio, V.;
Rigacci, L.;
Annibali, O.

Publication type:

Article

Recent advances in therapeutic strategies for non-small cell lung cancer.

Published in:

Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01679-1

By:

Su, Po-Lan;
Furuya, Naoki;
Asrar, Alahmadi;
Rolfo, Christian;
Li, Zihai;
Carbone, David P.;
He, Kai

Publication type:

Article

Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis.

Published in:

Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01678-2

By:

Wu, Yuze;
Yan, Yuheng;
Guo, Yarong;
Niu, Mengke;
Zhou, Binghan;
Zhang, Jing;
Zhou, Pengfei;
Chu, Qian;
Mei, Qi;
Yi, Ming;
Wu, Kongming

Publication type:

Article

BCMA-targeted therapies for multiple myeloma: latest updates from 2024 ASH annual meeting.

Published in:

Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01675-5

By:

Zheng, Huijian;
Xian, Huajian;
Zhang, Wenjie;
Lu, Chaoqun;
Pan, Renyao;
Liu, Han;
Xu, Zhenshu

Publication type:

Article